User login
New clinical research grants totaling more than $23 million have been awarded to support the development of diagnostics and treatments for patients with rare disease. More than 40% of the awards focus on treatments for children. The grants were awarded to investigators from academia and industry in the US and abroad through the FDA’s Office of Orphan Product Development.
New clinical research grants totaling more than $23 million have been awarded to support the development of diagnostics and treatments for patients with rare disease. More than 40% of the awards focus on treatments for children. The grants were awarded to investigators from academia and industry in the US and abroad through the FDA’s Office of Orphan Product Development.
New clinical research grants totaling more than $23 million have been awarded to support the development of diagnostics and treatments for patients with rare disease. More than 40% of the awards focus on treatments for children. The grants were awarded to investigators from academia and industry in the US and abroad through the FDA’s Office of Orphan Product Development.